论文信息 - CHAPTER 35 – IMMUNOTHERAPY VERSUS CHEMOIMMUNOTHERAPY AS ADJUVANT TREATMENT OF MALIGNANT MELANOMA - 字舞流文

CHAPTER 35 – IMMUNOTHERAPY VERSUS CHEMOIMMUNOTHERAPY AS ADJUVANT TREATMENT OF MALIGNANT MELANOMA

G. Mathé | B. Mével | B. Serrou | R. Plagne | J. Guerrin | R. Metz | Misset Jl | M. Schneider | C. Jeanne

[1] C. Chastang,et al. Adjuvant chemotherapy in the management of primary malignant melanoma , 1978 .

[2] M. Mardiney,et al. Alteration of cellular ribonucleases associated with murine oncogenic virus infection. , 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[3] D. Morton,et al. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. , 1976, The New England journal of medicine.

[4] S. Carter,et al. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. , 1974, Cancer treatment reviews.

[5] W. Clark,et al. The classification of malignant melanoma and its histologic reporting , 1973, Cancer.

[6] E. Hersh,et al. Active immunotherapy with B.C.G. for recurrent malignant melanoma. , 1973, Lancet.

[7] P. Ms,et al. PROTECTION AGAINST RUBELLA , 1965 .